Your browser doesn't support javascript.
loading
Oncolysate-loaded Escherichia coli bacterial ghosts enhance the stimulatory capacity of human dendritic cells.
Michalek, Jaroslav; Hezova, Renata; Turanek-Knötigova, Pavlina; Gabkova, Jana; Strioga, Marius; Lubitz, Werner; Kudela, Pavol.
Afiliación
  • Michalek J; Cellthera, s.r.o., Brno, Czech Republic.
  • Hezova R; Advanced Cell Immunotherapy Unit, Department of Pharmacology, Medical Faculty, Masaryk University, Brno, Czech Republic.
  • Turanek-Knötigova P; Department of Pediatrics, The University Hospital Brno, Brno, Czech Republic.
  • Gabkova J; Advanced Cell Immunotherapy Unit, Department of Pharmacology, Medical Faculty, Masaryk University, Brno, Czech Republic.
  • Strioga M; Advanced Cell Immunotherapy Unit, Department of Pharmacology, Medical Faculty, Masaryk University, Brno, Czech Republic.
  • Lubitz W; Department of Pharmacology and Immunotherapy, Veterinary Research Institute, Brno, Czech Republic.
  • Kudela P; Institute of Mathematics and Physics, Faculty of Mechanical Engineering, Slovak University of Technology, Bratislava, Slovak Republic.
Cancer Immunol Immunother ; 66(2): 149-159, 2017 Feb.
Article en En | MEDLINE | ID: mdl-27864613
ABSTRACT
The natural adjuvant properties of bacterial ghosts (BGs) lie within the presence of intact pathogen-associated molecular patterns on their surface. BGs can improve the direct delivery, natural processing and presentation of target antigens within dendritic cells (DCs). Moreover, sensitization of human DCs by cancer cell lysate (oncolysate)-loaded BGs in the presence of IFN-α and GM-CSF enhanced DC maturation as indicated by an increased expression of maturation markers and co-stimulatory molecules, higher production of IL-12p70 and stimulation of significantly increased proliferation of both autologous CD4+ and CD8+ T cells compared to DCs matured in the presence of purified lipopolysaccharide. The induced T cells efficiently recognized oncolysate-derived tumor-associated antigens expressed by cancer cells used for the production of oncolysate. Our optimized one-step simultaneous antigen delivery and DC maturation-inducing method emerges as a promising tool for the development and implementation of next-generation cellular cancer immunotherapies.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Células Dendríticas / Inmunoterapia Adoptiva / Escherichia coli Límite: Humans Idioma: En Revista: Cancer Immunol Immunother Asunto de la revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Año: 2017 Tipo del documento: Article País de afiliación: República Checa

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Células Dendríticas / Inmunoterapia Adoptiva / Escherichia coli Límite: Humans Idioma: En Revista: Cancer Immunol Immunother Asunto de la revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Año: 2017 Tipo del documento: Article País de afiliación: República Checa